Dynavax Technologies Corporation DSO Ratio 2011-2026 | DVAX

Annual DSO Ratio Dynavax Technologies Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
56.5	146	66	57.7	124	92.1	165	953	44.4	126	24.1	52.8	37.8	161

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
953	24.1	150

Quarterly DSO Ratio Dynavax Technologies Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
68.8	60	67.1	-	76.4	65.4	76.2	-	58.8	110	240	-	-	-	-	-	129	164	58.4	-	196	775	132	76.7	76.7	97.7	99.5	63.6	231	270	1.26 K	3.71 K	1.47 K	742	677	16.8	756	43.2	124	170	69.9	46.1	119	29.1	30	21.8	30.7	52.1	50.7	43.8	57.6	50.8	31.9	34.2	204	76.1	740	120	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
3.71 K	16.8	279

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	2.94 K	-	5743.5 %	$ 69.7 M	Canada
Coherus BioSciences CHRS	559	$ 1.57	-3.68 %	$ 184 M	USA
Happiness Biotech Group Limited HAPP	29	-	1.35 %	$ 17.8 M	China
Amphastar Pharmaceuticals AMPH	70.9	$ 16.87	-2.49 %	$ 789 M	USA
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Arcturus Therapeutics Holdings ARCT	21.2	$ 7.47	-4.6 %	$ 205 M	Israel
Eton Pharmaceuticals ETON	39.1	$ 30.26	1.0 %	$ 814 M	USA
Exelixis EXEL	43.4	$ 50.13	-1.9 %	$ 13.6 B	USA
Fortress Biotech FBIO	115	$ 2.41	4.78 %	$ 67.2 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
AbCellera Biologics ABCL	173	$ 4.09	-7.05 %	$ 1.22 B	Canada
Autolus Therapeutics plc AUTL	58.2	$ 1.63	2.52 %	$ 434 M	Britain
Celyad Oncology SA CYAD	64.4	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	47.6	-	-	$ 344 M	USA
IMV IMV	2.16 K	-	-	$ 13.1 M	Canada
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Gilead Sciences GILD	57.8	$ 129.58	-1.88 %	$ 161 B	USA
Advaxis ADXS	3.28 K	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 3.36	-3.72 %	$ 5.53 M	Israel
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	126	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Esperion Therapeutics ESPR	99.7	$ 3.12	-	$ 649 M	USA
Genmab A/S GMAB	97.9	$ 26.54	-1.34 %	$ 1.72 B	Danmark
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA